This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts Have Conflicting Sentiments on These Healthcare Companies: Incyte (INCY) and Option Care Health (OPCH)

Tipranks - Tipranks - Wed Jun 10, 4:44AM CDT

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Incyte (INCY) and Option Care Health (OPCH).

Introducing TipRanks MCP for Agents

Incyte (INCY)

BMO Capital analyst Evan Seigerman maintained a Sell rating on Incyte on June 7 and set a price target of $75.00. The company’s shares closed last Monday at $100.64.

According to TipRanks.com, Seigerman is a 4-star analyst with an average return of 6.4% and a 51.7% success rate. Seigerman covers the Healthcare sector, focusing on stocks such as Structure Therapeutics, Inc. Sponsored ADR, Vertex Pharmaceuticals, and ACADIA Pharmaceuticals. ;'>

Currently, the analyst consensus on Incyte is a Moderate Buy with an average price target of $109.93.

See the top stocks recommended by analysts >>

Option Care Health (OPCH)

Goldman Sachs analyst Scott Fidel initiated coverage with a Hold rating on Option Care Health yesterday and set a price target of $22.00. The company’s shares closed last Monday at $20.08.

According to TipRanks.com, Fidel is a 4-star analyst with an average return of 7.1% and a 62.9% success rate. Fidel covers the Healthcare sector, focusing on stocks such as Concentra Group Holdings Parent, Inc., BrightSpring Health Services, Inc., and Ardent Health Partners, Inc. ;'>

Option Care Health has an analyst consensus of Strong Buy, with a price target consensus of $30.00.

Read More on INCY:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).